Cetera Investment Advisers
PLSE icon

Cetera Investment Advisers’s Pulse Biosciences PLSE Stock Holding History

Cetera Investment Advisers’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$497K Sell
17,914
-14
-0.1% -$330 ﹤0.01% 3703
2026
Q1 		$387K Buy
+17,928
New +$331K ﹤0.01% 3747
2024
Q2 		– Sell
-13,370
Closed -$116K – 3825
2024
Q1 		$116K Buy
+13,370
New +$123K ﹤0.01% 3469

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Cetera Investment Advisers's PLSE Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Pulse Biosciences (PLSE) stake by 0.08% in Q2 2026, selling an estimated $330 and leaving 17,914 shares worth $497K. The position accounts for ﹤0.01% of the portfolio, ranked #3703.

Cetera Investment Advisers first reported a position in PLSE in Q1 2024 and has held it in 3 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Cetera Investment Advisers held 17,914 shares of Pulse Biosciences worth $497K as of Q2 2026.
  • Cetera Investment Advisers sold 14 Pulse Biosciences shares in Q2 2026, an estimated $330.
  • Pulse Biosciences made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3703 holding.
  • Cetera Investment Advisers first reported a position in Pulse Biosciences in Q1 2024 and has held it in 3 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.